Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Lee, Hyoung Gon ^a   Chen, Qun ^a   Wolfram, Julie A ^a   Richardson, Sandy L ^a   Liner, Anna ^a,c   Siedlak, Sandra L ^a   Zhu, Xiongwei ^a   Ziats, Nicholas P ^a   Fujioka, Hisashi ^a   Feisher, Dean W ^d   Castellani, Rudy J ^e   Valencik, Maria L ^f   McDonald, John A ^f   Hoit, Brian D ^a,c   Lesnefsky, Edward J ^a,b,g   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEVADA   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOGENESIS; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA REPLICATION; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL DNA DISORDER; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; ELECTRON TRANSPORT; FEMALE; HYPERTROPHY; METABOLISM; MITOCHONDRION; PATHOLOGY; PROMOTER REGION; TRANSGENIC MOUSE;

MUS;

ANIMALS; APOPTOSIS; CARDIOMYOPATHY, HYPERTROPHIC; CELL CYCLE; CELL PROLIFERATION; ELECTRON TRANSPORT; FEMALE; HEART FAILURE; HYPERTROPHY; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 70349836477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007172     Document Type: Article

References (42)

1. Komuro I, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62: 1075-1079.
2. Izumo S, Nadal-Ginard B, Mahdavi V (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A 85: 339-343.
3. Pollack PS, Houser SR, Budjak R, Goldman B (1994) c-myc gene expression is localized to the myocyte following hemodynamic overload in vivo. J Cell Biochem 54: 78-84.
4. Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P (1999) Drosophila myc regulates cellular growth during development. Cell 98: 779-790.
5. Grandori C, Cowley SM, James LP, Eisenman RN (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699.
6. Oster SK, Ho CS, Soucie EL, Penn LZ (2002) The myc oncogene: MarvelouslY Complex. Adv Cancer Res 84: 81-154.
7. Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2: 764-776.
8. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11.
9. Felsher DW, Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4: 199-207.
10. Karlsson A, Giuriato S, Tang F, Fung-Weier J, Levan G, et al. (2003) Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 101: 2797-2803.
11. Robbins RJ, Swain JL (1992) C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice. Am J Physiol 262: H590-597.
12. Reiss K, Capasso JM, Huang HE, Meggs LG, Li P, et al. (1993) ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am J Physiol 264: H760-769.
13. Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, et al. (1998) Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 83: 594-601.
14. Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, et al. (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15: 123-134.
15. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, et al. (2000) Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 45: 860-865.
16. Van Coster R, De Meirleir L (2000) Mitochondrial cytopathies and neuromuscular disorders. Acta Neurol Belg 100: 156-161.
17. Lucas DT, Aryal P, Szweda LI, Koch WJ, Leinwand LA (2003) Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 284: H575-583.
18. Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, et al. (2005) Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25: 6225-6234.
19. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, et al. (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106: 847-856.
20. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, et al. (2004) Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94: 525-533.
21. Valencik ML, McDonald JA (2001) Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Res 10: 269-275.
22. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ (2008) Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294: C460-466.
23. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, et al. (1997) Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol 273: H1544-1554.
24. Zhong W, Mao S, Tobis S, Angelis E, Jordan MC, et al. (2006) Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. Embo J 25: 3869-3879.
25. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, et al. (2001) Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 89: 1122-1129.
26. Hayashi M, Hayashi Y, Liu CY, Tichelaar JW, Kao WW (2005) Over expression of FGF7 enhances cell proliferation but fails to cause pathology in corneal epithelium of Kerapr-rtTA/FGF7 bitransgenic mice. Mol Vis 11: 201-207.
27. Suzuki M, Carlson KM, Marchuk DA, Rockman HA (2002) Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy. Circulation 105: 1824-1829.
28. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW (2007) Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 292: H2119-2130.
29. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, et al. (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 95: 8801-8805.
30. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, et al. (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757.
31. Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ (2009) PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 46: 201-212.
32. Buchwald A, Till H, Unterberg C, Oberschmidt R, Figulla HR, et al. (1990) Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur Heart J 11: 509-516.
33. Marin-Garcia J, Goldenthal MJ, Pierpont EM, Ananthakrishnan R, Perez-Atayde A (1999) Is age a contributory factor of mitochondrial bioenergetic decline and DNA defects in idiopathic dilated cardiomyopathy? Cardiovasc Pathol 8: 217-222.
34. Marin-Garcia J, Hu Y, Ananthakrishnan R, Pierpont ME, Pierpont GL, et al. (1996) A point mutation in the cytb gene of cardiac mtDNA associated with complex III deficiency in ischemic cardiomyopathy. Biochem Mol Biol Int 40: 487-495.
35. Quigley AF, Kapsa RM, Esmore D, Hale G, Byrne E (2000) Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J Card Fail 6: 47-55.
36. Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, et al. (2005) Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma. Blood 106: 1042-1047.
37. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, et al. (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 162: 1623-1627.
38. Zhu X, Wang Y, Ogawa O, Lee HG, Raina AK, et al. (2004) Neuroprotective properties of Bcl-w in Alzheimer disease. J Neurochem 89: 1233-1240.
39. Morgan EE, Faulx MD, McElfresh TA, Kung TA, Zawaneh MS, et al. (2004) Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 287: H2049-2053.
40. Hoppel CL, Kerr DS, Dahms B, Roessmann U (1987) Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. J Clin Invest 80: 71-77.
41. Krahenbuhl S, Chang M, Brass EP, Hoppel CL (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266: 20998-21003.
42. Lesnefsky EJ, Gudz TI, Moghaddas S, Migita CT, Ikeda_Saito M, et al. (2001) Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33: 37-47.